title: [Menopause - facts and controversies].
abstract: Menopausal period induces some hormonal changes in female organism. These alterations are responsible for many illnesses and ailments - e.g. disorders of menstrual cycle, climacteric symptoms, urine incontinence, connective tissue lesions, postmenopausal osteopenia and osteoporosis. All the changes negatively influence quality of life of women. The principal element of menopausal care in this period is hormone therapy (HT), alleviating many of the climacteric aliments. This article is focused also on some controversial topics concerning the HT action on breast, coronary system and brain.
authors.affiliation: Department of Gynecology and Menopausal Diseases, Polish Mother Memorial Hospital, Research Institute, Lodz, Poland. gstach23@interia.pl
authors.forename: Tomasz
authors.initials: T
authors.lastname: Pertyński
authors.forename: Grzegorz
authors.initials: G
authors.lastname: Stachowiak
mesh_terms: D000328:Adult; D000368:Aged; D004967:Estrogens / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D020249:Hormone Replacement Therapy / Q000009:adverse effects / Q000379:methods; D019584:Hot Flashes / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D008593:Menopause / Q000187:drug effects* / Q000502:physiology*; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy / Q000517:prevention & control*; D047648:Perimenopause / Q000187:drug effects / Q000502:physiology; D017698:Postmenopause / Q000187:drug effects / Q000502:physiology; D011372:Progestins / Q000494:pharmacology / Q000627:therapeutic use; D011788:Quality of Life; D014549:Urinary Incontinence / Q000188:drug therapy; D014564:Urogenital Abnormalities / Q000188:drug therapy
chemical_list: D004967:Estrogens; D011372:Progestins